{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:10:43Z","timestamp":1782472243367,"version":"3.54.5"},"reference-count":39,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1248\/bpb.b19-00775","type":"journal-article","created":{"date-parts":[[2019,12,25]],"date-time":"2019-12-25T22:02:07Z","timestamp":1577311327000},"page":"432-439","source":"Crossref","is-referenced-by-count":21,"title":["Extract of &lt;i&gt;Salvia przewalskii&lt;\/i&gt; Repair Tissue Damage in Chronic Hypoxia Maybe through the RhoA\u2013ROCK Signalling Pathway"],"prefix":"10.1248","volume":"43","author":[{"given":"Yafeng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of pharmacy, Qinghai Provincial People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Duo","sequence":"additional","affiliation":[{"name":"Department of pharmacy, Qinghai Provincial People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of pharmacy, Qinghai Provincial People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyue","family":"He","sequence":"additional","affiliation":[{"name":"Department of pharmacy, Qinghai Provincial People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of pharmacy, Qinghai Provincial People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of pharmacy, Qinghai Provincial People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of pharmacy, The First Hospital of Lanzhou University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Pratali L, Cavana M, Sicari R, Picano E. Frequent subclinical high-altitude pulmonary edema detected by chest sonography as ultrasound lung comets in recreational climbers. <i>Crit. Care Med.<\/i>, <b>38<\/b>, 1818\u20131823 (2010).","DOI":"10.1097\/CCM.0b013e3181e8ae0e"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Barry PW, Pollard AJ. Altitude illness. <i>BMJ<\/i>, <b>326<\/b>, 915\u2013919 (2003).","DOI":"10.1136\/bmj.326.7395.915"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Leon-Velarde F, Maggiorini M, Reeves JT, Aldashev A, Asmus I, Bernardi L, Ge RL, Hackett P, Kobayashi T, Moore LG, Penaloza D, Richalet JP, Roach R, Wu T, Vargas E, Zubieta-Castillo G, Zubieta-Calleja G. Consensus statement on chronic and subacute high altitude diseases. <i>High Alt. Med. Biol.<\/i>, <b>6<\/b>, 147\u2013157 (2005).","DOI":"10.1089\/ham.2005.6.147"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Gali\u00e8 N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension. <i>Eur. Respir. J.<\/i>, <b>34<\/b>, 1219\u20131263 (2009).","DOI":"10.1183\/09031936.00139009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hackett PH, Roach RC. High-altitude illness. <i>N. Engl. J. Med.<\/i>, <b>345<\/b>, 107\u2013114 (2001).","DOI":"10.1056\/NEJM200107123450206"},{"key":"6","unstructured":"6) Wang H, Gao XM, Zhang BL. Tanshinone: an inhibitor of proliferation of vascular smooth muscle cells. <i>J. Ethnopharmacol.<\/i>, <b>99<\/b>, 93\u201398 (2005)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fei YX, Wang SQ, Yang LJ, Qiu YY, Li YZ, Liu WY, Xi T, Fang WR, Li YM. <i>Salvia miltiorrhiza<\/i> Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats. <i>J. Ethnopharmacol.<\/i>, <b>207<\/b>, 57\u201366 (2017).","DOI":"10.1016\/j.jep.2017.06.023"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yu J, Gao H, Wu C, Xu QM, Lu JJ, Chen X. Diethyl blechnic, a novel natural product isolated from <i>Salvia miltiorrhiza<\/i> Bunge, inhibits doxorubicin-induced apoptosis by inhibiting ROS and activating JNK1\/2. <i>Int. J. Mol. Sci.<\/i>, <b>19<\/b>, 1809 (2018).","DOI":"10.3390\/ijms19061809"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Lin R, Wang WR, Liu JT, Yang GD, Han CJ. Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. <i>J. Ethnopharmacol.<\/i>, <b>108<\/b>, 217\u2013222 (2006).","DOI":"10.1016\/j.jep.2006.05.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Matkowski A, Zieli\u0144ska S, Oszmia\u0144ski J, Lamer-Zarawska E. Antioxidant activity of extracts from leaves and roots of <i>Salvia miltiorrhiza<\/i> Bunge, <i>S. przewalskii<\/i> Maxim., and <i>S. verticillata<\/i> L. <i>Bioresour. Technol.<\/i>, <b>99<\/b>, 7892\u20137896 (2008).","DOI":"10.1016\/j.biortech.2008.02.013"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Hao PP, Jiang F, Chen YG, Yang J, Zhang K, Zhang MX, Zhang C, Zhao YX, Zhang Y. Evidence for traditional Chinese medication to treat cardiovascular disease. <i>Nat. Rev. Cardiol.<\/i>, <b>12<\/b>, 374 (2015).","DOI":"10.1038\/nrcardio.2014.177-c2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Jia C, Han S, Wei L, Dang X, Niu Q, Chen M, Cao B, Liu Y, Jiao H. Protective effect of compound Danshen (<i>Salvia miltiorrhiza<\/i>) dripping pills alone and in combination with carbamazepine on kainic acid-induced temporal lobe epilepsy and cognitive impairment in rats. <i>Pharm. Biol<\/i>, <b>56<\/b>, 217\u2013224 (2018).","DOI":"10.1080\/13880209.2018.1432665"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Li X, Luo Y, Wang L, Li Y, Shi Y, Cui Y, Xue M. Acute and subacute toxicity of ethanol extracts from <i>Salvia przewalskii<\/i> Maxim in rodents. <i>J. Ethnopharmacol.<\/i>, <b>131<\/b>, 110\u2013115 (2010).","DOI":"10.1016\/j.jep.2010.06.012"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Chen T, Liu W, Chao X, Zhang L, Qu Y, Huo J, Fei Z. Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice. <i>Brain Res. Bull.<\/i>, <b>84<\/b>, 163\u2013168 (2011).","DOI":"10.1016\/j.brainresbull.2010.11.015"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Durairajan SSK, Yuan Q, Xie L, Chan WS, Kum WF, Koo I, Liu C, Song Y, Huang JD, Klein WL, Li M. Salvianolic acid B inhibits A beta fibril formation and disaggregates preformed fibrils and protects against A beta-induced cytotoxicty. <i>Neurochem. Int.<\/i>, <b>52<\/b>, 741\u2013750 (2008).","DOI":"10.1016\/j.neuint.2007.09.006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hao YB, Xie TP, Korotcov A, Zhou YF, Pang XW, Shan L, Ji H, Sridhar R, Wang P, Califano J, Gu X. Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma <i>in vitro<\/i> and <i>in vivo via<\/i> cyclooxygenase-2 and apoptotic pathways. <i>Int. J. Cancer<\/i>, <b>124<\/b>, 2200\u20132209 (2009).","DOI":"10.1002\/ijc.24160"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wang ZS, Luo P, Dai SH, Liu ZB, Zheng XR, Chen T. Salvianolic acid B induces apoptosis in human glioma U87 cells through p38-mediated ROS generation. <i>Cell. Mol. Neurobiol.<\/i>, <b>33<\/b>, 921\u2013928 (2013).","DOI":"10.1007\/s10571-013-9958-z"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sha W, Zhou Y, Ling ZQ, Xie G, Pang X, Wang P, Gu X. Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells <i>via<\/i> ceramide-mediated apoptosis. <i>Oncotarget<\/i>, <b>9<\/b>, 36331\u201336343 (2018).","DOI":"10.18632\/oncotarget.26348"},{"key":"19","unstructured":"19) Dhapare S, Sakagami M. Salvianolic acid B as an anti-emphysema agent I: <i>in vitro<\/i> stimulation of lung cell proliferation and migration, and protection against lung cell death, and <i>in vivo<\/i> lung STAT3 activation and VEGF elevation. <i>Pulm. Pharmacol. Ther.<\/i>, <b>53<\/b>, 107\u2013115 (2018)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yu PF, Wang WY, Eerdun G, Wang T, Zhang LM, Li C, Fu FH. The role of P-glycoprotein in transport of danshensu across the blood\u2013brain barrier. <i>Evid. Based Complement. Alternat. Med.<\/i>, <b>2011<\/b>, 713523 (2011).","DOI":"10.1155\/2011\/713523"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Chong CM, Su H, Lu JJ, Wang Y. The effects of bioactive components from the rhizome of <i>Salvia miltiorrhiza<\/i> (Danshen) on the characteristics of Alzheimer\u2019s disease. <i>Chin. Med.<\/i>, <b>14<\/b>, 19 (2019).","DOI":"10.1186\/s13020-019-0242-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Liu S, Han Z, Trivett AL, Lin H, Hannifin S, Yang D, Oppenheim JJ. Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma. <i>Cancer Immunol. Immunother.<\/i>, <b>68<\/b>, 1059\u20131071 (2019).","DOI":"10.1007\/s00262-019-02326-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Saraf RS, Datta A, Sima C, Hua J, Lopes R, Bittner M. An in-silico study examining the induction of apoptosis by Cryptotanshinone in metastatic melanoma cell lines. <i>BMC Cancer<\/i>, <b>18<\/b>, 855 (2018).","DOI":"10.1186\/s12885-018-4756-0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. <i>Eur. Respir. J.<\/i>, <b>53<\/b>, 1801913 (2019).","DOI":"10.1183\/13993003.01913-2018"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. <i>Nat. Chem. Biol.<\/i>, <b>4<\/b>, 278\u2013286 (2008).","DOI":"10.1038\/nchembio.85"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Arya A, Sethy NK, Singh SK, Das M, Bhargava K. Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation. <i>Int. J. Nanomedicine<\/i>, <b>8<\/b>, 4507\u20134520 (2013).","DOI":"10.2147\/IJN.S53032"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Ramanathan L, Gozal D, Siegel JM. Antioxidant response to chronic hypoxia in the rat cerebellum and pons. <i>J. Neurochem.<\/i>, <b>93<\/b>, 47\u201352 (2005).","DOI":"10.1111\/j.1471-4159.2004.02988.x"},{"key":"28","unstructured":"28) B\u00e4rtsch P, Swenson ER. Clinical practice: acute high-altitude illnesses. <i>N. Engl. J. Med.<\/i>, <b>368<\/b>, 2294\u20132302 (2013)."},{"key":"29","unstructured":"29) Aamand R, Dalsgaard T, Jensen FB, Simonsen U, Roepstorff A, Fago A. Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>297<\/b>, H2068\u2013H2074 (2009)."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Horscroft JA, Kotwica AO, Laner V, <i>et al.<\/i> Metabolic basis to Sherpa altitude adaptation. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>114<\/b>, 6382\u20136387 (2017).","DOI":"10.1073\/pnas.1700527114"},{"key":"31","unstructured":"31) Holden JE, Stone CK, Clark CM, Brown WD, Nickles RJ, Stanley C, Hochachka PW. Enhanced cardiac metabolism of plasma glucose in high-altitude natives: adaptation against chronic hypoxia. <i>J. Appl. Physiol.<\/i>, <b>79<\/b>, 222\u2013228 (1995)."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Han J, He Y, Zhao H, Xu X. Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN\/p65 signaling pathway. <i>J. Cell. Biochem.<\/i>, <b>120<\/b>, 14735\u201314744 (2019).","DOI":"10.1002\/jcb.28734"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hou Y, Ji N, Zhang H, Shi X, Han H, Lin S. Genome size-dependent pcna gene copy number in dinoflagellates and molecular evidence of retroposition as a major evolutionary mechanism. <i>J. Phycol.<\/i>, <b>55<\/b>, 37\u201346 (2019).","DOI":"10.1111\/jpy.12815"},{"key":"34","unstructured":"34) Kale J, Osterlund EJ, Andrews DW. BCL-2 family proteins: changing partners in the dance towards death. <i>Cell Death Differ.<\/i>, <b>25<\/b>, 65\u201380 (2018)."},{"key":"35","unstructured":"35) Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. <i>Genes Dev.<\/i>, <b>13<\/b>, 1501\u20131512 (1999)."},{"key":"36","unstructured":"36) Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. <i>Nat. Rev. Cancer<\/i>, <b>8<\/b>, 253\u2013267 (2008)."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. <i>J. Physiol.<\/i>, <b>522<\/b>, 177\u2013185 (2000).","DOI":"10.1111\/j.1469-7793.2000.t01-2-00177.x"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Etienne-Manneville S, Hall A. Rho GTPases in cell biology. <i>Nature<\/i>, <b>420<\/b>, 629\u2013635 (2002).","DOI":"10.1038\/nature01148"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Chanu P, Gao X, Bruno R, Claret L, Harnisch L. A modeling and simulation-based assessment of the impact of confounding factors on the readout of a sildenafil survival trial in pulmonary arterial hypertension. <i>J. Pharmacokinet. Pharmacodyn.<\/i>, <b>46<\/b>, 499\u2013509 (2019).","DOI":"10.1007\/s10928-019-09654-3"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/3\/43_b19-00775\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T03:19:51Z","timestamp":1583551191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/3\/43_b19-00775\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00775","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}